Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics
Cancers · 27.02.2025 · 17 (5) · 831
DOI: 10.3390/cancers17050831 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.02.2025. Verfasst von Vignesh Balaji Easwaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) are specialized cells that can differentiate into various types of cells. MSCs can be utilized to treat cancer. However, a MSC is considered a double-edged sword, because it can promote tumor progression and support cancer cell growth. Likewise, MSC-derived exosomes (MSC-Exos) carry various intracellular materials and transfer them to other cells. MSC-Exos could also cause tumor progression, including brain cancer, breast cancer, hepatic cancer, lung cancer, and colorectal cancer, and develop resistance against therapies, mainly chemotherapy, radiotherapy, and immunotherapy. An MSC-Exo promotes tumor development and causes drug resistance in various cancer types. The mechanisms involved in cancer drug resistance vary depending on the cancer cell heterogeneity and complexity. In this article, we have explained the various biomarkers and mechanisms involved in the tumor and resistance development through MSC-Exos in different cancer types.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
ORCID-Profile: K Sreedhara Ranganath Pai
Zitieren
APA
Easwaran, V. B., Pai, K. M. S., & Pai, K. S. R. (2025). Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics. Cancers, 17(5), 831. https://doi.org/10.3390/cancers17050831
Vancouver
Easwaran VB, Pai KMS, Pai KSR. Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics. Cancers. 2025;17(5):831. doi:10.3390/cancers17050831
BibTeX
@article{Easwaran2025,
author = {Easwaran, Vignesh Balaji and Pai, K Maya S and Pai, K Sreedhara Ranganath},
title = {Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics},
journal = {Cancers},
year = {2025},
volume = {17},
number = {5},
pages = {831},
doi = {10.3390/cancers17050831}
}
EUVIMED